A detailed history of Umb Bank, N.A. transactions in Vericel Corp stock. As of the latest transaction made, Umb Bank, N.A. holds 109 shares of VCEL stock, worth $6,179. This represents 0.0% of its overall portfolio holdings.

Number of Shares
109
Previous 31 251.61%
Holding current value
$6,179
Previous $1,000 300.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$42.25 - $53.56 $3,295 - $4,177
78 Added 251.61%
109 $4,000
Q2 2024

Jul 29, 2024

BUY
$41.71 - $52.9 $458 - $581
11 Added 55.0%
31 $1,000
Q1 2024

Apr 26, 2024

BUY
$32.52 - $52.33 $650 - $1,046
20 New
20 $1,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.67B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Umb Bank, N.A. Portfolio

Follow Umb Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.